ZA957699B - Bicyclic oxazole and thiazole substituted ethers - Google Patents

Bicyclic oxazole and thiazole substituted ethers

Info

Publication number
ZA957699B
ZA957699B ZA957699A ZA957699A ZA957699B ZA 957699 B ZA957699 B ZA 957699B ZA 957699 A ZA957699 A ZA 957699A ZA 957699 A ZA957699 A ZA 957699A ZA 957699 B ZA957699 B ZA 957699B
Authority
ZA
South Africa
Prior art keywords
oxazole
substituted ethers
thiazole substituted
bicyclic
bicyclic oxazole
Prior art date
Application number
ZA957699A
Other languages
English (en)
Inventor
Thomas D Aicher
Seung Hoon Cheon
Jeffrey Nadelson
William Ronald James Simpson
William Joseph Houlihan
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA957699B publication Critical patent/ZA957699B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA957699A 1994-09-13 1995-09-13 Bicyclic oxazole and thiazole substituted ethers ZA957699B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30524994A 1994-09-13 1994-09-13

Publications (1)

Publication Number Publication Date
ZA957699B true ZA957699B (en) 1997-03-13

Family

ID=23180015

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957699A ZA957699B (en) 1994-09-13 1995-09-13 Bicyclic oxazole and thiazole substituted ethers

Country Status (26)

Country Link
EP (1) EP0702015B1 (xx)
JP (1) JPH08109183A (xx)
KR (1) KR960010649A (xx)
CN (1) CN1130186A (xx)
AT (1) ATE158585T1 (xx)
AU (1) AU3055295A (xx)
BR (1) BR9504004A (xx)
CA (1) CA2157950A1 (xx)
CO (1) CO4410332A1 (xx)
CZ (1) CZ229595A3 (xx)
DE (1) DE69500758T2 (xx)
DK (1) DK0702015T3 (xx)
ES (1) ES2108550T3 (xx)
FI (1) FI954257A (xx)
GR (1) GR3025405T3 (xx)
HU (1) HUT73432A (xx)
IL (1) IL115235A0 (xx)
MY (1) MY132008A (xx)
NO (1) NO953569L (xx)
NZ (1) NZ272976A (xx)
PE (1) PE50296A1 (xx)
PL (1) PL310372A1 (xx)
SI (1) SI0702015T1 (xx)
SK (1) SK111195A3 (xx)
TR (1) TR199501115A2 (xx)
ZA (1) ZA957699B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002314744A1 (en) 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
DE10333935A1 (de) * 2003-07-25 2005-02-24 Aventis Pharma Deutschland Gmbh Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2858321B1 (fr) * 2003-07-28 2006-01-20 Servier Lab Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
DE69326736T2 (de) * 1992-08-31 2000-06-08 Sankyo Co Oxazolidin-Derivate mit Antidiabetika und Anti-Fettleibigkeit-Eigenschaften, ihre Herstellung und therapeutische Verwendung
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5521202A (en) * 1993-04-07 1996-05-28 Taiho Pharmaceutical Co., Ltd. Thiazolidine derivatives and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
SK111195A3 (en) 1997-06-04
NO953569L (no) 1996-03-14
CA2157950A1 (en) 1996-03-14
GR3025405T3 (en) 1998-02-27
HU9502663D0 (en) 1995-11-28
CN1130186A (zh) 1996-09-04
DE69500758T2 (de) 1998-02-26
NZ272976A (en) 1996-09-25
JPH08109183A (ja) 1996-04-30
FI954257A0 (fi) 1995-09-11
NO953569D0 (no) 1995-09-11
AU3055295A (en) 1996-03-28
SI0702015T1 (en) 1998-02-28
PE50296A1 (es) 1996-12-05
MY132008A (en) 2007-09-28
FI954257A (fi) 1996-03-14
EP0702015B1 (en) 1997-09-24
DK0702015T3 (da) 1998-01-12
CO4410332A1 (es) 1997-01-09
CZ229595A3 (en) 1996-04-17
HUT73432A (en) 1996-07-29
KR960010649A (ko) 1996-04-20
IL115235A0 (en) 1995-12-31
PL310372A1 (en) 1996-03-18
ES2108550T3 (es) 1997-12-16
DE69500758D1 (de) 1997-10-30
TR199501115A2 (tr) 1996-06-21
BR9504004A (pt) 1996-09-24
ATE158585T1 (de) 1997-10-15
EP0702015A1 (en) 1996-03-20

Similar Documents

Publication Publication Date Title
NZ237565A (en) Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof
AU645672C (en) Agents for preserving technical materials against insects
GR3033350T3 (en) Use of Beta-aminopropionic acid derivatives as fungicides
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
AU2008995A (en) Improvements in or relating to organic compounds
ZA957699B (en) Bicyclic oxazole and thiazole substituted ethers
BR9304780A (pt) Composto, processo para preparar o composto, composição farmacêutica e uso
TW241264B (xx)
AU2704492A (en) Improvements in or relating to organic compounds
EP0381114A3 (en) Exo-3',4'-0-benzylidene-3"-demethylchartreusin and its salts
AU6029090A (en) Improvements in or relating to organic compounds
EP1364951A4 (en) PESTICIDES
DE69410159T2 (de) Neue Verbindung, Leustroducsin H, ihre Herstellung und therapeutische Verwendung